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Longitudinal Trends in Childhood Insulin Levels and Body Mass Index
and Associations With Risks of Psychosis and Depression
in Young Adults
Benjamin I. Perry, MRCPsych; Jan Stochl, PhD; Rachel Upthegrove, PhD; Stan Zammit, PhD; Nick Wareham, PhD;
Claudia Langenberg, PhD; Eleanor Winpenny, PhD; David Dunger, PhD;
Peter B. Jones, PhD; Golam M. Khandaker, PhD
IMPORTANCE Cardiometabolic disorders often occur concomitantly with psychosis and
depression, contribute to high mortality rates, and are detectable from the onset of the
psychiatric disorders. However, it is unclear whether longitudinal trends in cardiometabolic
traits from childhood are associated with risks for adult psychosis and depression.
OBJECTIVE To examine whether specific developmental trajectories of fasting insulin (FI)
levels and body mass index (BMI) from early childhood were longitudinally associated with
psychosis and depression in young adults.
DESIGN, SETTING, AND PARTICIPANTS A cohort study from the Avon Longitudinal Study of
Parents and Children, a prospective study including a population-representative British
cohort of 14 975 individuals, was conducted using data from participants aged 1 to 24 years.
Body mass index and FI level data were used for growth mixture modeling to delineate
developmental trajectories, and associations with psychosis and depression were assessed.
The study was conducted between July 15, 2019, and March 24, 2020.
EXPOSURES Fasting insulin levels were measured at 9, 15, 18, and 24 years, and BMI was
measured at 1, 2, 3, 4, 7, 9, 10, 11, 12, 15, 18, and 24 years. Data on sex, race/ethnicity, paternal
social class, childhood emotional and behavioral problems, and cumulative scores of sleep
problems, average calorie intake, physical activity, smoking, and alcohol and substance use
in childhood and adolescence were examined as potential confounders.
MAIN OUTCOMES AND MEASURES Psychosis risk (definite psychotic experiences, psychotic
disorder, at-risk mental state status, and negative symptom score) depression risk (measured
using the computerized Clinical Interview Schedule–Revised) were assessed at 24 years.
RESULTS From data available on 5790 participants (3132 [54.1%] female) for FI levels and
data available on 10 463 participants (5336 [51.0%] female) for BMI, 3 distinct trajectories
for FI levels and 5 distinct trajectories for BMI were noted, all of which were differentiated
by mid-childhood. The persistently high FI level trajectory was associated with a psychosis
at-risk mental state (adjusted odds ratio [aOR], 5.01; 95% CI, 1.76-13.19) and psychotic
disorder (aOR, 3.22; 95% CI, 1.11-9.90) but not depression (aOR, 1.38; 95% CI, 0.75-2.54).
A puberty-onset major increase in BMI was associated with depression (aOR, 4.46; 95% CI,
2.38-9.87) but not psychosis (aOR, 1.98; 95% CI, 0.56-7.79).
CONCLUSIONS AND RELEVANCE The cardiometabolic comorbidity of psychosis and depression
may have distinct, disorder-specific early-life origins. Disrupted insulin sensitivity could be
a shared risk factor for comorbid cardiometabolic disorders and psychosis. A puberty-onset
major increase in BMI could be a risk factor or risk indicator for adult depression. These
markers may represent targets for prevention and treatment of cardiometabolic disorders
in individuals with psychosis and depression.
JAMA Psychiatry. doi:10.1001/jamapsychiatry.2020.4180
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C ardiometabolic disorders often occur concomitantlywith depression and schizophrenia,1 leading to a re-duced quality of life, increased health care costs,2 and
a shortened life expectancy.3,4 Traditionally, this comorbid-
ity has been attributed to chronic lifestyle factors (eg, physi-
cal inactivity or smoking) or the adverse effects of psychotro-
pic medications.5 However, meta-analyses report altered
glucose-insulin homeostasis in relatively young, drug-naive
patients with first-episode psychosis.6,7 Similarly, reports
from population-based longitudinal studies suggest a bidirec-
tional association between depression and cardiovascular
disease.8,9 Together, this evidence suggests that cardiometa-
bolic and psychiatric conditions may share pathophysiologic
mechanisms. However, 2 key issues remain.
First, existing studies have predominantly included preva-
lent depression or psychosis cases and so cannot appropri-
ately test the direction of association between cardiometa-
bolic and psychiatric phenotypes.10 Second, most longitudinal
studies have included one-off measures of cardiometabolic
indices, overlooking dynamic temporal changes in these
markers.11,12 Longitudinal repeated measurements could pro-
vide a more reliable measure of underlying homeostatic mecha-
nisms and could identify population subgroups. For ex-
ample, aberrant trajectories of childhood body mass index
(BMI) are associated with adult cardiometabolic disorders.13
Although cardiometabolic function encompasses a broad range
of parameters, 2 pathways—insulin sensitivity and adiposity—
are of particular interest regarding psychosis and depression.
Genetic studies have indicated associations of BMI with
depression14 and fasting insulin (FI) levels with schizophrenia.15
However, to our knowledge, no studies have examined whether
FI level and BMI trajectories from childhood are associated with
adult psychosis and depression.
Using data from the Avon Longitudinal Study of Parents
and Children (ALSPAC) birth cohort, we aimed to (1) delineate
longitudinal trajectories of FI level and BMI based on re-
peated measurements in individuals between ages 1 and
24 years, (2) examine the characteristics of identified trajec-
tories, and (3) test associations with risks of psychosis and
depression at 24 years in the total sample and by sex. We
hypothesized that altered cardiometabolic development
from childhood would be associated with increased risks for
depression and psychosis in adulthood.
Methods
Cohort and Sample
The ALSPAC initially recruited 14 541 pregnant residents
in southwest England, with expected delivery dates between
April 1, 1991, and December 31, 1992, resulting in 14 062 live
births.16-18 An additional 913 participants were recruited sub-
sequently. Participants received financial compensation. Data
were collected and managed using REDCap (University of
Bristol19,20). Modeling of the trajectories was performed using
5790 participants for FI levels and 10 463 participants for BMI
(eFigure 1 in the Supplement). Missing exposure data were
handled using full-information maximum likelihood estima-
tion (eMethods in the Supplement). Data were deidentified.
The ALSPAC Ethics and Law Committee and local research eth-
ics committees provided ethical approval for the ALSPAC
cohort study. Ethical approval for the present study was
obtained via the ALSPAC Executive Committee. Consent for
biological samples was collected in accordance with the
Human Tissue Act of 2004 covering England, Wales and
Northern Ireland. Informed consent for all collected data was
obtained from participants following the recommendations of
the ALSPAC Ethics and Law Committee at the time. This study
followed the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) reporting guideline for
cohort study.
Measurement of Exposures
Fasting insulin levels were measured at ages 9 (n = 894),
15 (n = 3484), 18 (n = 3286), and 24 (n = 3253) years, using an
ultrasensitive automated microparticle enzyme immunoas-
say (Mercodia), which does not cross-react with proinsulin.
Sensitivity of the immunoassay was 0.07 mU/L, and interas-
say and intraassay coefficients of variation were less than 6%.
Fasting blood samples were drawn at 9 AM after a 10-hour fast,
then spun and stored at −80 °C. There was no evidence of
freeze-thaw cycles during storage.
Body mass index, calculated as weight in kilograms
divided by height in meters squared, was measured at
1 (n = 1236), 2 (n = 1036), 3 (n = 1050), 4 (n = 1018), 7 (n = 8200),
9 (n = 7633), 10 (n = 7465), 11 (n = 7100), 12 (n = 6704),
15 (n = 5415), 18 (n = 5061), and 24 (n = 3975) years.
Psychiatric Outcomes at Age 24 Years
Psychotic experiences (PEs) were identified through the semi-
structured Psychosis-Like Symptom Interview21 conducted by
trained psychology graduates and coded per the definitions in
the Schedules for Clinical Assessment in Neuropsychiatry, ver-
sion 2.0.22 The Psychosis-Like Symptom Interview had good
interrater (intraclass correlation: 0.81; 95% CI, 0.68-0.89) and
test-retest (0.9; 95% CI, 0.83-0.95) reliability. Psychotic expe-
riences occurring in the past 6 months covered the 3 main posi-
tive symptom domains: hallucinations, delusions, and thought
Key Points
Question Are longitudinal trends in insulin levels and body mass
index from childhood associated with adult depression and
psychosis?
Findings This cohort study of repeated-measure data from age 1
to 24 years in up to 10 463 individuals identified trajectories of
fasting insulin levels and body mass index. Persistently high fasting
insulin levels from age 9 years were associated with psychosis
at 24 years, and puberty-onset body mass index increase was
associated with depression at 24 years.
Meaning This study’s findings suggest that changes in insulin
sensitivity and adiposity starting from childhood may have
disorder-specific associations with psychosis and depression and
represent targets for prevention and treatment of cardiometabolic
disorders in people with psychosis and depression.
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interference. After cross-questioning, interviewers rated PEs
as absent, suspected, or definite. We included cases of defi-
nite PEs; the comparator group comprised individuals with
suspected or absent PEs.
Cases of at-risk mental state were identified by mapping
Psychosis-Like Symptom Interview data to Comprehensive
Assessment of At-Risk Mental State (CAARMS) criteria.23 Cases
were defined as participants meeting CAARMS criteria for
attenuated psychosis (symptoms not reaching the psychosis
threshold owing to levels of intensity or frequency) or brief
limited intermittent psychosis (frank psychotic symptoms
that resolved spontaneously within 1 week).
Cases of psychotic disorder were defined21 as definite PEs
that were not attributable to sleep or fever, had occurred
more than once per month during the previous 6 months, and
were very distressing or negatively impactful on social/
occupational functioning, and led to seeking of professional
help. We also included participants meeting the criteria for
CAARMS psychotic disorder (threshold psychotic symptoms
occurring for >1 week).
Ten questions from the Community Assessment of
Psychic Experiences questionnaire24 were administered cov-
ering interest, motivation, emotional reactivity, pleasure,
and sociability. Participants rated each item as 0 (never),
1 (sometimes), 2 (often), and 3 (always). We recoded the vari-
ables by scoring always and often as 1 and never and some-
times as 0, and then summed the values to result in a pos-
sible total score of 0 to 10.
Depression was measured using the computerized Clini-
cal Interview Schedule–Revised.25 The interview assesses symp-
toms of depression occurring in the past week and provides
a diagnosis of depressive episode based on the International
Statistical Classification of Diseases, Tenth Revision criteria, which
we used as a binary outcome (codes F32.0-32.2). We also in-
cluded a Clinical Interview Schedule–Revised depression se-
verity score, comprising scores for mood, thoughts, fatigue,
concentration, and sleep, as a continuous outcome.
For assessment of potential confounders, we included sex
at birth, race/ethnicity, paternal social class, childhood emo-
tional and behavioral problems (measured using the Strength
and Difficulties Questionnaire26 at age 7 years), and cumula-
tive scores of smoking, physical activity, alcohol use, sub-
stance use, sleep problems, and average calorie intake
between ages 7 and 24 years (eMethods in the Supplement).
Statistical Analysis
We standardized (z transformed) FI levels and BMI separately
in males and females and then combined the sex-stratified
z scores for each variable at each time point to delineate tra-
jectories using curvilinear growth mixture modeling27
(eMethods in the Supplement). We used z scores to measure
the relative change in FI levels and BMI because BMI in-
creases in all young people during early life. Because the sample
size for FI levels at age 9 years was smaller, we repeated growth
mixture modeling without age-9-years data and compared the
characteristics of the resultant trajectories. Analyses were con-
ducted using MPlus, version 8 (Muthén & Muthén), and R, ver-
sion 3.6.0 (R Project for Statistical Computing). Two-tailed
P values were corrected for multiple testing using the Holm-
Bonferroni method28 for the 6 psychiatric outcomes. A cor-
rected P value <.05 was used as the threshold for signifi-
cance. We estimated how participants overlapped between
BMI and FI level trajectories (the most common and highest
risk) using the φ correlation coefficient.
We used the 3-step method29 to estimate associations of
sociodemographic, lifestyle, and clinical factors with trajec-
tory membership (eMethods in the Supplement). The 3-step
method allows class separation unaffected by auxiliary vari-
ables, retains and includes information on class uncertainty,
and is robust when entropy is greater than 0.60. Multinomial
regression was used to estimate odds ratios (ORs) and 95% CIs
for the associations of sociodemographic and lifestyle factors
with FI level and BMI trajectories compared with the most com-
mon trajectory. We considered time-invariant (sex, ethnicity,
social class at birth, family history of cardiovascular disease,
gestational age, birth weight, and perinatal stressful life events)
and time-variant (physical activity and smoking in adoles-
cence and early adulthood) factors. Odds ratios represent the
increase in the risk of membership of a particular trajectory
category per SD increase in factor. Next, we examined the clini-
cal phenotype of trajectories at 24 years, examining mean lev-
els of commonly measured clinical and biochemical factors for
participants grouped by most-likely trajectory membership
(eMethods in the Supplement). Next, we used logistic regres-
sion to estimate the association of trajectory membership with
an age-appropriate cardiometabolic outcome: metabolic syn-
drome at 24 years (eMethods in the Supplement).
Using the 3-step method, logistic regression was used to
estimate ORs and 95% CIs for binary outcomes per trajectory,
compared with the most common trajectory. Linear regres-
sion for continuous outcomes was used to estimate β coeffi-
cients and 95% CIs representing the SD increase in the risk of
outcomes per trajectory. We tested associations for the total
sample and separately by sex before and after adjusting for
potential confounders. Regression models for negative symp-
toms were additionally adjusted for depressive symptoms, and
vice versa.
Results
Trajectories of FI Levels and BMI
Based on 5790 participants (2658 [45.9%] male, 3132 [54.1%]
female), the 3-trajectory solution for FI levels was optimum,
representing stable average (class 1: 4939 [77.8%]), minor in-
crease (class 2: 693 [19.0%]), and persistently high (class 3: 158
[3.1%]) trajectories between ages 9 and 24 years (Figure 1A;
eTable 1 and eFigure 2 in the Supplement). The trajectories were
similar after excluding age-9-years data (eFigure 3 in the
Supplement).
Based on 10 463 participants (5336 [51.0%] female, 5127
[49.0%] male) included in the analysis of BMI, the 5-trajec-
tory solution was optimum, representing stable average
(class 1: 8383 [71.1%]), gradually decreasing (class 2: 949 [7.0%]),
puberty-onset minor increase (class 3: 668 [14.5%]), puberty-
onset major increase (class 4: 174 [1.9%]), and persistently high
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(class 5: 289 [5.5%]) BMI trajectories between ages 1 and 24
years (Figure 1B; eTable 2 and eFigure 4 in the Supplement).
The stable average FI level and BMI trajectories were sta-
tistically significantly correlated (rφ = 0.233, P < .001), as were
the persistently high trajectories (rφ = 0.092, P < .001).
Both deviating FI level trajectories were associated with
lower social class, family history of cardiometabolic disease,
lower physical activity, and smoking in adolescence and early
adulthood. Lower birth weight and more perinatal stressful life
events were associated with the persistently high trajectory
compared with the stable average trajectory (eTable 3 in the
Supplement). The persistently high trajectory cohort also had
mean FI, high-density lipoprotein cholesterol, triglyceride, and
C-reactive protein levels outside of UK reference ranges at
24 years (eTable 4 in the Supplement). Deviating FI level tra-
jectories were associated with metabolic syndrome at 24 years
(adjusted OR [aOR] for the persistently high trajectory, 9.21;
95% CI, 3.77-20.15) (eTable 5 in the Supplement).
Deviating BMI trajectories were associated with lower
social class, family history of cardiometabolic disease, more
perinatal stressful life events, lower physical activity, and smok-
ing in adolescence and early adulthood compared with the
stable average trajectory. Higher birth weight was associated
with the gradually decreasing and persistently high trajecto-
ries, whereas lower birth weight was weakly associated with
both puberty-onset increase trajectories (eTable 6 in the
Supplement). Deviating BMI trajectories were also associ-
ated with mean values of waist circumference and FI, high-
density lipoprotein cholesterol, and C-reactive protein levels
outside of UK reference ranges at 24 years (eTable 7 in the
Supplement). All deviating BMI trajectories were associated
with metabolic syndrome at 24 years (aOR for the persis-
tently high trajectory, 10.62; 95% CI, 5.89-19.13) (eTable 5 in
the Supplement).
Associations of FI and BMI Trajectories
With Psychiatric Outcomes
The persistently high FI level trajectory was associated with
the psychosis at-risk mental state (aOR, 5.01; 95% CI, 1.76-
13.19), psychotic disorder (aOR, 3.22; 95% CI, 1.11-9.90), and
negative symptoms (adjusted β, 0.07; 95% CI, 0.01-0.13) at age
24 years. Fasting insulin level trajectories were not associ-
ated with depression (aOR, 1.38; 95% CI, 0.75-2.54) (Table 1;
Figure 2A; eTable 8 in the Supplement).
The puberty-onset major increase trajectory of BMI was
associated with a higher risk of a depressive episode (aOR, 4.46;






















































A, Fasting insulin levels measured at ages 9 to 24 years in 5790 participants.
Class 1 (stable average) comprised 77.8% of the sample; class 2 (minor increase),
19.0%; and class 3 (persistently high), 3.1%. B, Body mass index measured at
ages 1 to 24 years in 10 463 participants. Class 1 (stable average) comprised
71.1% of the sample; class 2 (gradually decreasing), 7.0%; class 3 (puberty-onset
minor increase), 14.5%; class 4 (puberty-onset major increase), 1.9%; and class
5 (persistently high), 5.5%. Trajectories were delineated using growth mixture
modeling at 4 time points for fasting insulin and 12 time points for body mass
index. Nodes in the graph represent mean z scores for fasting insulin level or
body mass index at each time point for each developmental trajectory.
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95% CI, 2.38-9.87) and depressive symptoms (adjusted β, 0.08;
95% CI, 0.03-0.14) at age 24 years. The puberty-onset minor
increase trajectory was weakly associated with depressive
symptoms at 24 years (adjusted β, 0.06; 95% CI, 0.01-0.11).
Body mass index trajectories were not associated with psy-
chosis outcomes (aOR for psychotic disorder in the puberty-
onset major increase trajectory, 1.98; 95% CI, 0.56-7.79) (Table 2
and Figure 2B; eTable 9 in the Supplement).
Sex-Stratified Associations of Risks for Psychiatric Outcomes
For FI trajectories, the pattern of association with risks for psy-
chiatric outcomes in sex-stratified analysis was similar to the
primary analysis. For example, point estimates for the associa-
tion between the persistently high FI trajectory and psychotic
disorder were similar in males (aOR, 3.94; 95% CI, 1.10-11.96)
compared with females (aOR, 2.50; 95% CI, 0.57-11.09), and
95% CIs overlapped. There was no association between
persistently high FI and depression in males (aOR, 0.95; 95%
CI, 0.22-4.12) or females (aOR, 1.50; 95% CI, 0.76-2.96) (Figure 3;
eTable 10 and eTable 11 in the Supplement). For BMI, point
estimates for depression for both puberty-onset increase tra-
jectories were larger in females. For example, for the puberty-
onset major increase trajectory, the association for females
(aOR, 6.28; 95% CI, 2.14-18.44) was stronger than for males (aOR,
2.23; 95% CI, 0.41-12.72). There was no significant association
of BMI trajectories with psychosis outcomes. For example, there
was no association between puberty-onset major BMI
increase and psychotic disorder for males (aOR, 1.62; 95% CI,
0.71-3.98) or females (aOR, 2.60; 95% CI, 0.66-8.21) (Figure 3;
eTable 12 and eTable 13 in the Supplement).
Discussion
We delineated FI level and BMI trajectories from early life, using
prospective repeated measurements in a large population-
representative birth cohort, and report distinct associations
with psychosis and depression measured in adulthood. After
adjusting for a number of relevant confounders, we found that
persistently high FI levels from mid-childhood appeared to be
associated with an increased risk of psychosis outcomes at age
24 years, while BMI increases around the age of puberty on-
set were associated with depression at age 24 years. Associa-
tions of BMI and FI level trajectories with cardiometabolic risk
factors, such as social class, ethnicity, smoking, physical ac-
tivity, and adult metabolic syndrome, suggest face validity to
the identified trajectories. Although the last data point for BMI
and FI levels overlapped with the outcome assessment, the tra-
jectories were differentiated by mid-childhood, suggesting a
temporal association between exposure and outcome. Evi-
dence for the association of puberty-onset BMI increase and
adult depression remained after adjusting for childhood emo-
tional and behavioral problems, suggesting that a reverse
direction of association may not fully explain this finding. Al-
though the same adjustment may be less capable of ruling out
reverse direction of the association between persistently high
FI levels and psychosis, it is unlikely that many participants
had experienced psychosis before age 9 years, and so a re-
verse direction of association is unlikely.
We found consistent evidence for an association be-
tween FI level trajectories and psychosis outcomes. Effect sizes
were largest in the persistently high trajectory, consistent with
a dose-response relationship, and point estimates were larger
in more clinically relevant outcomes. Our findings comple-
ment meta-analyses reporting altered glucose-insulin homeo-
stasis in first-episode psychosis.6,7 Moreover, our results sug-
gest that disruptions to glucose-insulin homeostasis detectable
at first-episode psychosis in adults may begin in childhood. The
point estimates partly attenuated after adjustment for con-
founders, suggesting that malleable lifestyle factors, such as
smoking, physical activity, and diet, should remain targets for
reducing the risk of incident cardiometabolic disorders in
Table 1. Psychosis and Depressive Outcomes at Age 24 Years Associated With Fasting Insulin Level Trajectories
From Age 9 to 24 Years
Trajectory and outcome at 24 y
Sample,
No.
Odds ratio (95% CI)
P valuebUnadjusted Adjusteda
Definite PE
Class 1: stable average 4939 1 [Reference] 1 [Reference]
Class 2: minor increase 693 1.48 (0.98-2.24) 1.31 (0.56-3.35) .31
Class 3: persistently high 158 1.88 (1.05-3.60) 1.50 (0.98-2.41) .33
Psychosis at-risk mental state
Class 1: stable average 4939 1 [Reference] 1 [Reference]
Class 2: minor increase 693 1.59 (0.20-8.02) 1.36 (0.32-5.76) >.99
Class 3: persistently high 158 6.33 (1.97-20.30) 5.01 (1.76-13.19) .006
Psychotic disorder
Class 1: stable average 4939 1.00 [reference] 1.00 [Reference]
Class 2: minor increase 693 1.85 (0.70-4.88) 1.23 (0.55-2.74) >.99
Class 3: persistently high 158 4.74 (1.67-13.42) 3.22 (1.11-9.90) .05
Depressive episode
Class 1: stable average 4939 1 [Reference] 1 [Reference]
Class 2: minor increase 693 1.26 (0.73-2.67) 1.36 (0.57-2.81) .88
Class 3: persistently high 158 1.31 (0.81-4.32) 1.38 (0.75-2.54) .69
Abbreviation: PE, psychotic
experience.
a Adjusted for sex, ethnicity, social
class, Strength and Difficulties
Questionnaire (measured at 7 years)
findings, and cumulative scores for
smoking, physical activity, alcohol
and substance use, sleep problems,
and calorie intake.
b P values adjusted for multiple
testing using the Holm-Bonferroni
method.
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young people with psychosis. We also found that participants
classified into the persistently high FI level trajectory, who had
the highest risk of psychosis, had mean BMI and fasting plasma
glucose values within reference ranges at age 24 years. There-
fore, the risk of incident cardiometabolic disorders in these in-
dividuals may not be detected in psychosis early-interven-
tion services, since commonly measured physical indices may
not identify them. Consequently, careful assessment and clini-
cal considerations are needed to minimize the risk of cardio-
metabolic disorders in these individuals.
Our findings suggest that altered glucose-insulin homeo-
stasis could be a shared mechanism for psychosis and type 2 dia-
betes, which could be genetic and/or environmental in origin.
People with comorbid schizophrenia and type 2 diabetes have
a higher genetic predisposition for both disorders compared with
controls,30 and genetic predisposition for schizophrenia is as-
sociated with insulin resistance in patients with schizophrenia.31
In addition, we found that the persistently high FI trajectory,
which had the strongest associations with psychosis out-
comes, was also associated with lower birth weight and peri-
natal stressful life events. We noted similar patterns of associa-
tion in BMI trajectories that were associated with depression.
These findings are consistent with the fetal programming
hypothesis,32 which posits that disruption in early-life devel-
opment can have broad influences on adult health.
Our findings regarding the association of BMI trajectories
withdepressionatage24yearsareinlinewithmeta-analyses33,34
suggesting an association between BMI and risk of depression.
Similar trajectories of BMI have been linked with adult type 2
diabetes,35 obesity,36 and coronary heart disease.37 The charac-
ter and composition of BMI trajectories we identified are con-
sistent with those of previous studies, although our length of
follow-up was longer than the follow-up of most previous
studies.38
Our findings provide further insights into the link be-
tween BMI and depression,34 suggesting that puberty-onset in-
creases in BMI specifically are associated with risk of adult de-
pression. This finding, together with the lack of evidence for
an association between persistently high BMI and depression,
indicates that BMI might be a risk indicator for depression rather
than a risk factor because individuals in the persistently high
BMI trajectory would likely have been exposed to the “largest
Figure 2. Associations of Fasting Insulin Levels and Body Mass Index Trajectories With Psychosis and Depressive Outcomes
in the Avon Longitudinal Study of Parents and Children












Class 1 1 [Reference]
Class 2 1.31 (0.56-3.35)
Class 3 1.50 (0.98-2.41)
Psychosis ARMS
Class 1 1 [Reference]
Class 2 1.36 (0.32-5.76)
Class 3 5.01 (1.76-13.19)
Psychotic disorder
Class 1 1 [Reference]
Class 2 1.23 (0.55-2.74)
Class 3 3.22 (1.11-9.90)
Depressive episode
Class 1 1 [Reference]
Class 2 1.36 (0.57-2.81)
Class 3 1.38 (0.75-2.54)












Class 1 1 [Reference]
Class 2 1.26 (0.79-1.99)
Class 3 1.22 (0.79-1.89)
Psychosis ARMS
Class 1 1 [Reference]
Class 2 0.71 (0.19-2.89)
Class 3 1.09 (0.26-4.58)
Psychotic disorder
Class 1 1 [Reference]
Class 2 0.52 (0.11-2.46)
Class 3 1.57 (0.64-3.85)
Class 4 1.98 (0.56-7.79)
Class 5 1.87 (0.44-8.06)
Depressive episode
Class 1 1 [Reference]
Class 2 1.18 (0.75-1.92)
Class 3 1.40 (0.81-2.55)
Class 4 4.46 (2.38-9.87)
Class 5 2.07 (0.64-6.62)
Class 4 1.97 (0.56-6.92)
Class 5 2.44 (1.00-5.65)
Class 4 1.14 (0.15-12.22)
Class 5 1.29 (0.18-10.29)
Stable average Gradually decreasing
Puberty-onset major increase Persistently high
Puberty-onset minor
increase
Stable average Minor increase Persistently high
Adjusted odds ratios (ORs) and 95% CIs showing associations of fasting
insulin (A) and body mass index (B) trajectories from childhood with risk of
psychosis and depression outcomes at age 24 years after adjusting for sex,
ethnicity, social class, childhood emotional and behavioral problems, and
cumulative scores of smoking, physical activity, alcohol and substance use,
sleep problems, and calorie intake. ARMS indicates at-risk mental state;
PE, psychotic experiences.
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dose” of BMI. Therefore, if BMI were the risk factor, one would
have expected the largest effect size for depression in that tra-
jectory. Consequently, environmental and/or genetic factors
influencing BMI during puberty are likely to be important risk
factors for depression. For instance, social stressors, such as bul-
lying, may predispose to altered eating behaviors and an in-
creased risk of depression in adolescents.39 In addition, devi-
ating childhood BMI trajectories have been associated with a
greater risk of adolescent and adult eating disorders,40 which
are commonly comorbid with depression.41 Also, the effects of
estrogen may be relevant, since the associations of puberty-
onset BMI increases and depression appeared to be stronger in
females than males. Changes in estrogen levels are associated
with depressive symptoms throughout life in women, includ-
ing pregnancy,42 menopause,43 and puberty.44 Estrogen is
associated with obesity45 and may explain the genetic corre-
lation of age at menarche with adult obesity46 and depression.47
Further research is needed to identify factors influencing
pubertal BMI increases, as they may represent important pre-
ventive targets for depression.
We did not find consistent evidence for associations of
FI level trajectories with depression or of BMI trajectories with
psychosis. Previous research has reported mixed findings re-
garding the association between insulin resistance and de-
pression in young adults.48,49 However, some estimates for the
associations of BMI trajectories with psychosis outcomes in our
analyses had wide 95% CIs, possibly owing to sample size.
These particular findings require replication in larger samples
of people with psychosis.
Strengths and Limitations
Strengths of the study include a longitudinal design with re-
peated measurements of BMI and FI levels between ages 1 and
24 years in a relatively large sample enabling a detailed ex-
amination of dynamic cardiometabolic changes from child-
hood to early adulthood. We included several relevant depres-
sion and psychosis outcomes, which allowed us to examine for
specificity and for a biological gradient of evidence.
Limitations of the study include missing data. Although
we used a robust method to handle missing data, full-
information maximum likelihood may be biased in instances
in which data were not missing at random.50 However, the risk
of bias in full-information maximum likelihood is no greater
than the bias associated with traditional complete-case
methods,51 and full-information maximum likelihood permit-
ted a larger sample size and therefore increased statistical
power. Nevertheless, missing psychiatric outcome data may
have affected our results. Furthermore, although we ad-
justed for a number of relevant potential confounders, re-
sidual confounding could still be an issue. For example, we
could not account for psychological stress since data on cor-
tisol levels were available only at age 9 years in a small sub-
section of the cohort. Therefore, further research is needed,
such as mendelian randomization analysis, to examine for
potentially unconfounded associations. In addition, the 95%
CIs were relatively wide for the sex-stratified analysis, likely
owing to reduced statistical power. Therefore, replication
of our work in larger samples is required. In addition, the
ALSPAC data set does not include International Statistical
Table 2. Psychiatric Outcomes at Age 24 Years Associated With BMI Trajectories From Age 1 to 24 Years
Trajectory and outcome at 24 y
Sample,
No.
Odds ratio (95% CI)
P valuebUnadjusted Adjusteda
Definite PE
Class 1: stable average 8383 1 [Reference] 1 [Reference]
Class 2: gradually decreasing 949 1.43 (0.82-1.96) 1.26 (0.79-1.99) >.99
Class 3: puberty-onset minor increase 668 1.66 (0.87-2.55) 1.22 (0.79-1.89) >.99
Class 4: puberty-onset major increase 174 3.56 (0.87-11.54) 1.97 (0.56-6.92) >.99
Class 5: persistently high 289 3.21 (1.01-9.11) 2.44 (1.00-5.65) .37
Psychosis at-risk mental state
Class 1: stable average 8383 1 [Reference] 1 [Reference]
Class 2: gradually decreasing 949 0.49 (0.10-3.21) 0.71 (0.19-2.89) >.99
Class 3: puberty-onset minor increase 668 1.12 (0.23-5.43) 1.09 (0.26-4.58) >.99
Class 4: puberty-onset major increase 174 1.32 (0.10-13.11) 1.14 (0.15-12.22) >.99
Class 5: persistently high 289 1.55 (0.44-3.21) 1.29 (0.18-10.29) >.99
Psychotic disorder
Class 1: stable average 8383 1 [Reference] 1 [Reference]
Class 2: gradually decreasing 949 0.44 (0.21-2.03) 0.52 (0.11-2.46) >.99
Class 3: puberty-onset minor increase 668 1.97 (0.60-3.46) 1.57 (0.64-3.85) >.99
Class 4: puberty-onset major increase 174 2.14 (0.65-6.21) 1.98 (0.56-7.79) >.99
Class 5: persistently high 289 3.11 (0.53-13.22) 1.87 (0.44-8.06) >.99
Depressive episode
Class 1: stable average 8383 1 [Reference] 1 [Reference]
Class 2: gradually decreasing 949 1.33 (0.77-1.88) 1.18 (0.75-1.92) >.99
Class 3: puberty-onset minor increase 668 1.69 (0.90-3.21) 1.40 (0.81-2.55) .31
Class 4: puberty-onset major increase 174 8.91 (4.21-17.12) 4.46 (2.38-9.87) .006
Class 5: persistently high 289 3.01 (0.91-7.59) 2.07 (0.64-6.62) .44
Abbreviations: BMI, body mass index;
PE, psychotic experience.
a Adjusted for sex, ethnicity, social
class, Strength and Difficulties
Questionnaire (measured at
7 years), and cumulative scores for
smoking, physical activity, alcohol
and substance use, sleep problems,
and calorie intake.
b P values adjusted for multiple
testing using the Holm-Bonferroni
method.
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Figure 3. Sex-Stratified Associations of Fasting Insulin Levels and Body Mass Index Trajectories With Psychosis and Depressive Outcomes
in the Avon Longitudinal Study of Parents and Children
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Class 1 1 [Reference]
Class 2 1.35 (0.90-2.01)
Class 3 1.52 (1.08-2.29)
Class 4 6.28 (2.14-18.44)
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Class 4 0.81 (0.24-2.77)
Class 5 1.79 (0.90-3.49)
Class 4 1.41 (0.28-5.43)
Class 5 1.09 (0.31-4.88)
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Adjusted odds ratios (ORs) and 95% CIs showing associations of fasting insulin
level trajectories in males (A) and females (B) and body mass index trajectories
in males (C) and females (D) from childhood with risk of psychosis and
depression outcomes at age 24 years after adjusting for sex, ethnicity, social
class, childhood emotional and behavioral problems, and cumulative scores of
smoking, physical activity, alcohol and substance use, sleep problems, and
calorie intake. ARMS indicates at-risk mental state; PE, psychotic experience.
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Classification of Diseases and DSM diagnoses of schizophre-
nia. However, our psychotic disorder outcome would likely
meet the threshold for clinical intervention, and all our psy-
chosis outcomes lie on the schizophrenia continuum.
Conclusions
We report that the cardiometabolic comorbidity of psycho-
sis and depression may have distinct early-life origins. Dis-
rupted insulin sensitivity from mid-childhood appeared to
be associated with adult psychosis, and BMI increases start-
ing around the time of puberty onset were associated with
adult depression. Although residual confounding may be
an issue, our results suggest that these cardiometabolic
markers could be among shared risk factors and indicators
for adult cardiometabolic and psychiatric disorders and may
represent novel targets for prevention and treatment of
cardiometabolic disorders in people with psychosis and
depression.
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